Status:
UNKNOWN
A Multi-center, Non-interventional Prospective Clinical Trial to Evaluate the Safety and Effectiveness of CVA-FLOW
Lead Sponsor:
Cvaid Medical
Collaborating Sponsors:
Donawa Lifescience Consulting
Conditions:
Stroke
Eligibility:
All Genders
21+ years
Brief Summary
CVAid Medical Ltd. developed a smartphone-based tele stroke system named CVA-Flow. This system aims to evaluate the patient's neurological status, particularly detection of a possible stroke, assessme...
Detailed Description
Management of acute ischemic stroke has changed dramatically following the evidence of the superiority of endovascular treatment (EVT) over best medical management, in the treatment of patients suffer...
Eligibility Criteria
Inclusion
- Age ≥21 years of age
- With suspected acute stroke at the ED prior to treatment (tPA or EVT)
Exclusion
- Patient intubated upon arrival
- Patient treated with tPA prior to arrival at the ED
- Patients with the following conditions:
- Brain tumors
- Hypoglycemia
- Toxic poisoning
- Seizures
- Sepsis
- Subdural hematoma
- Encephalopathy (uremic, hepatic or other)
- Encephalitis
- Previous stroke with permanent neurological deficit
Key Trial Info
Start Date :
October 23 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2024
Estimated Enrollment :
460 Patients enrolled
Trial Details
Trial ID
NCT06101004
Start Date
October 23 2023
End Date
May 30 2024
Last Update
October 25 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
2
Hospital Vall d'Hebron - Neurology
Barcelona, Spain, 08035